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New Findings
 What is the topic of this review?
This review briefly considers what modulates sympathetic nerve activity and how it may
change as we age or in pathological conditions. It then focuses on transcutaneous vagus nerve
stimulation, a method of neuromodulation in autonomic cardiovascular control.
 What advances does it highlight?
The review considers the pathways involved in eliciting the changes in autonomic balance
seen with transcutaneous vagus nerve stimulation in relationship to other neuromodulatory
techniques.
The autonomic nervous system, consisting of the sympathetic and parasympathetic branches, is
a major contributor to the maintenance of cardiovascular variables within homeostatic limits.
As we age or in certain pathological conditions, the balance between the two branches changes
such that sympathetic activity is more dominant, and this change in dominance is negatively
correlated with prognosis in conditions such as heart failure. We have shown that non-invasive
stimulation of the tragus of the ear increases parasympathetic activity and reduces sympathetic
activity and that the extent of this effect is correlatedwith the baseline cardiovascular parameters
of different subjects. The effects could be attributable to activation of the afferent branch of the
vagus and, potentially, other sensory nerves in that region. This indicates that tragus stimulation
may be a viable treatment in disorders where autonomic activity to the heart is compromised.
(Received 16 August 2017; accepted after revision 10 November 2017; first published online 11 November 2017)
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Introduction
The autonomic nervous system is pivotal in homeostatic
control of many end organs. For organs that receive dual
innervation from the sympathetic and parasympathetic
branches of the autonomic nervous system, such as the
heart, eyes, bladder, bowel and sex organs, it provides a
way in which fine control of activity can be managed by
altering the balance of activity in the two branches that
mainly act reciprocally. The extent to which each branch
contributes to theoverall level of activity varies throughout
life, with differences observed during healthy ageing but
also in specific conditions, such as heart failure, where
sympathetic activity predominates and may contribute
to the detrimental effects on cardiovascular function.
Our aim is to understand what contributes to resting
sympathetic activity and how we may restore autonomic
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balance in these situations where sympathetic activity is
abnormally raised or parasympathetic activity is lowered,
potentially enabling simple novel interventions to be used
as alternative or adjunct therapies in such conditions.
Sympathetic activity at rest
The sympathetic nervous outflow is regulated by complex
CNS circuitry that receives afferent information and
culminates in outflow from the CNS through sympathetic
preganglionic neurones located in the thoracolumbar
regions of the spinal cord. The axons of these neurones
exit the spinal cord to innervate postganglionic neurones
that in turn innervate their target organs (Deuchars &
Lall, 2015). The activity of sympathetic preganglionic
neurones dictates the level of excitability in the outflow
to different end organs, which needs to be kept within
homeostatic limits.
There are a number of influences converging onto
sympathetic preganglionic activity. Sensory information
from specialized receptors causes reflex changes (involving
either spinal or supraspinal circuits) in sympathetic
activity that act to enable the body to respond app-
ropriately to the original stimulus, whether this is
stretching of baroreceptors because of a change in
blood pressure or a noxious stimulus that requires an
autonomic component to the response. Other descending
pathways from a number of brain regions contribute to
the overall activity, and the extent of this influence may
alter in situations of mental stress (Callister et al. 1992),
pathologies such as heart failure (discussed below) or as
a circadian change (Grassi et al. 2010). Many of these
pathways involve interneurones, some of which are in
close vicinity to the sympathetic outflows (Deuchars &
Lall, 2015). These sympathetic preganglionic neurones are
also electrically coupled through gap junctions composed
of connexin 36 subunits that enable appropriately
synchronized responses to specific perturbations (Lall
et al. 2017). Knockout of connexin subunits increases
variance in blood pressure and heart rate in conscious
mice, especially when a running wheel is introduced into
their cage. Furthermore, in anaesthetized animals or in the
anaesthetic-free working heart–brainstem preparation,
the sympathetic or cardiovascular responses to sensory
stimulation, such as activation of peripheral chemo-
receptors or noxious pinch, are significantly reduced
(Fig. 1). It is, therefore, clear that sympathetic activity is
precisely controlled through both intrinsic and extrinsic
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Figure 1. Sympathetic and heart rate responses to chemoreceptor or noxious stimulation are blunted
in the connexin 36 knockout (KO) mouse
Each panel shows the raw data, obtained using the working heart–brainstem preparation, with
sympathetic nerve discharge (SND), integrated sympathetic nerve activity (SND) and perfusion pressure
(pp) and the mean data for integrated sympathetic nerve discharge. Sympathoexcitation upon
chemoreceptor stimulation or noxious pinch (arrow denotes point of stimulation) is significantly reduced
in Cx36 KO mice compared with wild-type. Adapted from Lall et al. (2017), with permission.
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mechanisms, and activation of these different inputs may
enable modulation of this activity when required.
The character of cardiovascular autonomic activity is
related to age
Cardiovascular health is dictated by changes in autonomic
activity that lead to altered blood pressure, cardiac
function and responses to exercise, for example. The
contributions of the different branches of the autonomic
nervous system to cardiovascular autonomic function are
oftenassessednon-invasively inhumansusingheart rateor
blood pressure variability analysis. Heart rate varies from
beat to beat, and these variations reflect parasympathetic
and sympathetic inputs to the sinoatrial node. The
high-frequency component of heart rate variability is
considered to be related to rapid variations in heart
rate associated with vagally mediated respiratory sinus
arrhythmia (Malliani, 2005). In conscious dogs, this
component is abolished by parasympathetic blockade
using glycopyrrolate (Akselrod et al. 1981). Research
suggests that as people age, the contribution of the
parasympathetic activity to the heart declines, whereas
sympathetic tone increases. Using heart rate variability
and changes in respiratory sinus arrhythmia as measures
of vagal tone (De Meersman & Stein, 2007; Abhishekh
et al. 2013), there is a decline in parasympathetic control
of the heart. Concomitantly, with ageing, there is an
increase in sympathetic activity, measured as higher
plasma noradrenaline concentrations (Esler et al. 1995) or
increased muscle sympathetic activity (Ebert et al. 1992;
Ng et al. 1993). Our research has also shown this positive
correlation between age and baseline heart rate variability
(Fig. 2). This change in autonomic balance is associated
with an increased likelihood of developing cardiovascular
disease (Umetani et al. 1998; Abhishekh et al. 2013), and
thus, restoration of this balance in ageing has merited
consideration as a therapeutic target.
In cardiovascular disease, such as heart failure,
autonomic function is also affected
Many people in the UK today are living with a diagnosis
of heart failure that can be described simply as a reduction
in pumping capacity of the heart but in fact is a complex
syndrome arising from many different causes, such as a
heart attack, high blood pressure or cardiomyopathy. It
is well established that in heart failure, there is a chronic
elevation in sympathetic activity, measured as increased
plasma noradrenaline concentrations (Cohn et al. 1984;
Kaye et al. 1995) ormuscle sympathetic activity (Macefield
et al. 1999; Barretto et al. 2009); both measurements
positively correlatedwith increasedmortality. There is also
vagal withdrawal (Eckberg et al. 1971; Imai et al. 1994),
suggesting impaired parasympathetic function. Overall,
therefore, heart rate variability is impaired in heart failure
patients (Nolan et al. 1998), with such a close correlation
with mortality rate that it may be considered a predictor
of prognosis after myocardial infarction (La Rovere et al.
1998).
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Figure 2. Relationship between low-frequency to high-frequency (LF/HF) ratio and effects of
transcutaneous vagus nerve stimulation
A, plotting the baseline LF/HF ratio against age shows a significant relationship between these
parameters (R2 = 0.19; P = 0.013). B, there is a relationship between baseline LF/HF ratio and change
in LF/HF ratio during transcutaneous vagus nerve stimulation, indicating that higher LF/HF ratios predict
a greater decrease in LF/HF during transcutaneous vagus nerve stimulation (R2 = 0.58; P < 0.0005).
Adapted with permission from Clancy et al. (2014).
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Non-invasive stimulation of the tragus changes
autonomic balance
Neuromodulation is fast becoming a technique considered
as a therapeutic avenue in conditions as diverse as obesity,
urinary function and chronic pain. Similar methods,
such as vagus nerve stimulation, spinal cord stimulation,
renal denervation or baroreceptor activation, have been
studied for treatments of heart failure but with mixed
outcomes at clinical trial (Schwartz et al. 2015). In a bid to
identify non-invasive mechanisms to maintain or restore
autonomic balance to healthy levels, we investigated the
effects of stimulating nerves that run in the outer parts
of the ear, based on previous studies that suggested
that electroacupuncture of this region could reduce the
dependence of patients with coronary artery disease
on their vasodilator medication (Zamotrinsky et al.
1997, 2001) and increase their exercise tolerance. We
found that stimulation of the tragus part of the ear,
using specific stimulation parameters established in the
laboratory (200 µs pulses at 30 Hz 10–50 mA, which
was slightly below the level at which subjects could feel
the stimulus) significantly decreased the low-frequency to
high-frequency ratio (LF/HF) of the heart rate variability,
indicative of an increase in parasympathetic activity.
Furthermore, by measuring muscle sympathetic nerve
activity directly, using microneurography and specific
tests to identify individual units as being of sympathetic
origin, stimulation of the tragus significantly reduced the
incidence of firing of single sympathetic fibres (Clancy
et al. 2014). These results suggested that autonomic
balance was being altered by this intervention to increase
the vagal contribution. The extent of effectiveness of
this simple treatment was clearly seen by the significant
correlation between the magnitudes of the effects
compared with the resting LF/HF ratio of the subjects
(Fig. 2). This suggests that in conditions with higher
resting sympathetic contribution to heart rate variability,
such as ageing or heart failure, it is more likely that this
treatment will restore balance towards a vagal influence.
Indeed, our most recent cohort of subjects, taken from
both ageing populations and those with heart failure, are
consistent with these observations.
What are the pathways underlying these effects
on heart rate variability?
If we are to understand fully whether such an intervention
can be useful in the treatment of conditions such as
heart failure, it is crucial to elucidate the pathways
being activated by this transcutaneous vagus nerve
stimulation. This is particularly pertinent when one
considers the recent clinical trials of whole-nerve vagus
nerve stimulation in the treatment of conditions such
as heart failure, where the results were less promising
than hoped (Byku & Mann, 2016). This prompted
some extensive reflection on the reasons behind the
disappointing results. One major difference between
the trials concerns the stimulation parameters (both
amplitude of current and time of stimulation), a huge
consideration when one considers that the nerve being
activated is formed of small-diameter unmyelinated
C fibres along with myelinated A and B fibres (Byku
& Mann, 2016), all of which have different activation
thresholds. Thus, for each trial, a different assortment
of fibres may be stimulated. Furthermore, the vagus
nerve contains both afferent and efferent fibres, and some
studies were designed preferentially to activate the efferent
side, yet studies in cats report that in fact afferent vagal
stimulation significantly inhibits sympathetic activity
(Schwartz et al. 1973), and this may therefore be a more
relevant therapeutic avenue to ameliorate the increase in
cardiac sympathetic outflow to the heart. Perhaps a greater
issue is the recent report that the cervical vagus in humans
mayalso contain sympatheticfibres (Verlinden et al.2016),
so stimulating this nerve at the neck may concomitantly
activate sympathetic and parasympathetic efferent fibres.
Choosing a neuromodulatory regime that preferentially
activates afferent fibres may therefore be more effective.
The site at which we stimulate the ear is one that has
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Figure 3. Potential pathways involved in cardiovascular
responses elicited by stimulation of the tragus
The pathways in green represent
the potential afferent inputs to the CNS, with the dotted
lines being those under investigation. Red pathways are
interneurones involved in the autonomic modulation, while
vagal efferent pathways are in orange and the sympathetic
components of the pathways are in blue. Abbreviations:
Pa5, paratrigeminal nucleus; DVN, dorsal vagal motor
nucleus; NA, nucleus ambiguus; RVLM, rostral ventrolateral
medulla; CVLM, caudal ventrolateral medulla; DH, dorsal horn;
IML, intermediolateral cell column; SA Node, sinoatrial node.
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since been tested for treatment of atrial fibrillation
(Stavrakis et al. 2015) as well as conditions that are not
cardiovascular related, such as chronic pain, tinnitus and
epilepsy (Clancy et al. 2013; Murray et al. 2016). The
tragus is innervated by a purely sensory branch of the
vagus nerve, known as the auricular branch of the vagus,
which could explain the significant sympatho-inhibitory
effects observed with stimulating this region, considering
the findings of Schwartz et al. (1973) considered above.
However, this region of the ear is also innervated by the
great auricular nerve and the auriculotemporal nerve
(Peuker & Filler, 2002), so it is not necessarily solely vagus
nerve stimulation that is eliciting these effects. Functional
MRI studies have shown in the brain that transcutaneous
vagus nerve stimulation (at tragus, 250 µs pulse width,
4–8 mA) activates regions of the brain associated with the
vagal afferent input synaptic pathway, such as the locus
coeruleus of the brainstem, the thalamus, the prefrontal
cortex, the postcentral gyrus, the posterior cingulate
gyrus and the insula cortex (Dietrich et al. 2008). These
regions were mainly ipsilaterally activated, and their
responses differed from that of Kraus et al. (2007),
probably owing to differences in stimulation parameters
(20 µs pulse width, 8 Hz). Moreover, no focus has been
placed on spinal cord sites activated by tragus stimulation,
which may be a great oversight because, for example, the
great auricular nerve is considered a superior branch of
the cervical plexus (Ginsberg & Eicher, 2000). Indeed,
neuronal tracing techniques, using cholera toxin B, of
the primary afferent terminal projections from the tragus
equivalent in the rat suggest that there is a major spinal
afferent projection that merits further consideration
(M Mohadi, J Deuchars and SA Deuchars, unpublished
observations). These regions include the paratrigeminal
nucleus and the dorsal horn of the spinal cord (Fig. 3).
By stimulating a variety of sites within the ear, which
are innervated to different extents by the great auricular
nerve, auricular branch of the vagus or auriculotemporal
nerve, we will elucidate the contributions of the different
afferent nerves to the effects seen.
Conclusion
In conclusion, non-invasive neuromodulatory techniques
have the potential to provide simple and inexpensive
approaches to facilitating autonomic balance. Given that
the pathways underlying the actions are not fully explored,
further understanding is required to reveal how these may
best positively influence autonomic circuits.
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